Vibativ was recently approved by the FDA for the treatment of complicated skin and skin structure infections. “We are very pleased with the FDA’s approval of VIBATIV, and extremely excited about the prospect of bringing this new medicine to the market,” said Rick E Winningham, Theravance’s Chief Executive Officer. “This is a significant event that […]
Continue ReadingTop 200 Pharmaceuticals
July 20, 2009
………………………………………………………………………………………………………………………………….. A research group out of Cornell University has created really interesting poster of the top 200 pharmaceutical drug names by retail sales. The poster not only ranks each name, but also shows its chemical structure. The research group is call Njardarson Group. It is made up of visiting scientists, post-doctoral fellows, graduate students, undergraduate […]
Continue ReadingPfizer – Wyeth Merger
February 27, 2009
On January 25th, Pfizer leapfrogged over the tradition of buying smaller research companies to purchase Wyeth for 68 billion dollars. With their forces combined, Pfizer/Wyeth becomes the 4th largest US-based company; Exxon, Walmart, and Proctor & Gamble hold the top three spots. The merger process can be complicated and delicate to finagle on the finance […]
Continue ReadingHappy 110th Merck Manual!
February 23, 2009
…………………………………………………………………………………………………………………………………………………. The year 2009 marks the 110th anniversary of The Merck Manual, the best-selling and oldest continuously published general medical text in the English language. And what a 110 years it has been! It all started in 1899, when the American drug manufacturer Merck & Co. published a small book titled Merck’s Manual of the […]
Continue ReadingRember’s Early Success
August 26, 2008
The drug called Rember (methylthioninium chloride) is receiving substantial press in the news and medical world for its success in slowing the progress of mental deterioration associated with Alzheimer’s disease. The Alzheimer’s drugs currently available {Aricept, Exelon, Razadyne (previously Reminyl), Cognex, and Namenda} have been said to only ease the symptoms of the mind-robbing disease. […]
Continue ReadingTrend Watch: Drug Delivery
August 19, 2008
…………………………………………………………………………………………………………………………………………………. As pharmaceuticals are becoming more sophisticated, the need for targeted and effective modes of administration is becoming more apparent: a trend that is not being ignored by companies worldwide. Drug delivery is an increasingly dynamic sector of the pharmaceutical industry, and it may prove to be one of the most interesting areas of growth […]
Continue ReadingZipzor
July 22, 2008
Xanodyne Pharmaceuticals, Inc. Receives Approvable Letter From the U.S. FDA for ZIPSOR(TM) Capsules. Contributed by Laine Beyerl
Continue ReadingBanning Pharmaceutical Logos in Hospitals
June 04, 2008
A health system located in Minnesota and Wisconsin recently prohibited all branded materials within its 4 hospitals and 17 clinics. This new policy, that has been said to be “one of the toughest in the nation,” prohibits pharmaceutical companies from influencing doctors by limiting and controlling interaction between drug reps and doctors and excluding everything […]
Continue ReadingDefending the Empty Vessel Approach to Naming
May 08, 2008
…………………………………………………………………………………………………………………………………………………. Maghan Cook, Verbal Branding Associate for Addison Whitney, was recently published in the May 2008 issue of PharmaVOICE. Please click here to view an abstract of her article on Defending the Empty Vessel Approach to Naming. By: Trista Thielker
Continue ReadingYou Have the Flu Too?
April 18, 2008
It’s not just your imagination- it seems like everyone has been sick this flu season. Even the top 24 finalists of American Idol were unfortunate enough to fall victim to bronchitis and the flu. What makes one flu season worse than another? Each year, different strains of the influenza virus circulate throughout the world. About […]
Continue Reading